abagovomab 27
abciximab 26
abituzumab 20
abrilumab 18
actoxumab 14
adalimumab 16
aducanumab 9
afasevikumab 16
alacizumab_pegol 11
alemtuzumab 22
alirocumab 17
amatuximab 34
andecaliximab 20
anifrolumab 20
anrukinzumab 18
aprutumab 12
aprutumab_ixadotin 12
arcitumomab 21
ascrinvacumab 7
atezolizumab 15
atinumab 12
avelumab 13
basiliximab 26
bavituximab 32
begelomab 22
benralizumab 25
bevacizumab_beta 21
bezlotoxumab 14
bimagrumab 10
bleselumab 13
blinatumomab 32
blosozumab 27
bococizumab 16
brazikumab 11
brentuximab_vedotin 22
briakinumab 15
brodalumab 10
brolucizumab 26
brontictuzumab 22
burosumab 15
cabiralizumab 23
camrelizumab 14
canakinumab 24
cantuzumab_ravtansin 44
carlumab 14
carotuximab 24
cergutuzumab_amunaleukin2 22
cergutuzumab_amunaleukin 22
certolizumab_pegol 24
cetiximab 38
citatuzumab_bogatox 25
cixutumumab 21
clivatuzumab_tetraxetan 17
codrituzumab 30
conatumumab 6
concizumab 31
crenezumab 19
crizanlizumab 21
crotedumab 18
dacetuzumab 19
daclizumab 10
dalotuzumab 33
dapirolizumab_pegol 24
daratumumab 13
dectrekumab 9
demcizumab 21
denosumab 10
depatuxizumab 18
depatuxizumab_mafodotin 18
dezamizumab 18
dinutuximab 34
diridavumab 15
domagrozumab 14
drozitumab 12
duligotuzumab 18
durvalumab 9
dusigitumab 10
efalizumab 29
efungumab 27
eldelumab 11
elezanumab 15
elgemtumab 8
elotuzumab 16
emactuzumab 18
emapalumab 23
emibetuzumab 12
enavatuzumab 23
enfortumab_vedotin 11
enoblituzumab 16
enokizumab 19
enoticumab 14
ensituximab 28
eptinezumab 17
erenumab 15
etaracizumab 17
etrolizumab 21
evinacumab 21
evolocumab 11
farletuzumab 13
fasinumab 20
fezakinumab 13
fibatuzumab 8
ficlatuzumab 15
firivumab 31
flanvotumab 14
fletikumab 17
foralumab 9
foravirumab 12
fremanezumab 25
fresolimumab 17
fulranumab 19
futuximab 20
galcanezumab 15
ganitumab 25
gantenerumab 10
gemetuzumab 24
gemtuzumab2 24
gemtuzumab 22
gevokizumab 19
girentuximab 25
glembatumumab 15
glembatumumab_vedotin 15
guselkumab 19
ibalizumab 24
ibritumomab 26
icrucumab 6
idarucizumab 28
ifabotuzumab 8
imalumab 16
imgatuzumab 16
inclacumab 11
indatuximab_ravtansin 28
indusatumab 13
inebilizumab 27
intetumumab 11
iodine_girentuximab 27
ipilimumab 3
iratumumab 9
isatuximab 33
itolizumab 22
ixekizumab 30
labetuzumab_govitecan 19
lambrolizumab 25
lampalizumab 21
lanadelumab 16
landogrozumab 16
laprituximab 21
lebrikizumab 34
lendalizumab 21
lenzilumab 12
lifastuzumab_vedotin 22
ligelizumab 21
lilotomab 34
lirilumab 17
lodelcizumab 15
lokivetmab 24
lorvotuzumab_mertansin 22
lucatumumab 26
lumretuzumab 14
lupartumab 7
lutikizumab 19
margetuximab 31
milatuzumab 33
mirvetuximab 31
mirvetuximab_soravtansin 31
modotuximab 33
mogamulizumab 32
monalizumab 16
motavizumab 27
moxetumomab_pasudotox 28
namilumab 12
naratuximab 23
naratuximab_emtansin 23
narnatumab 13
navicixizumab2 24
navicixizumab 22
navivumab 34
necitumumab 9
nemolizumab 22
nesvacumab 13
nivolumab 10
obiltoxaximab 19
obinutuzumab 33
ocaratuzumab 25
ofatumumab 14
olaratumab 18
olokizumab 24
omalizumab 20
onartuzumab 20
ontuxizumab 20
opicinumab 13
orticumab 9
otelixizumab 34
oxelumab 10
ozanezumab 25
pamrevlumab 9
panobacumab 21
parsatuzumab 22
pasotuxizumab 20
pateclizumab 14
patritumab 15
pembrolizumab 25
perakizumab 17
pidilizumab 18
pinatuzumab_vedotin 17
plozalizumab 28
pogalizumab 22
polatuzumab_vedotin 19
ponezumab 32
prezalumab 12
pritoxaximab 27
quilizumab 20
racotumomab 22
radretumab 14
ralpancizumab 19
ramucirumab 13
ranevetmab 18
ranibizumab 23
refanezumab 23
remtolumab 16
rilotumumab 15
rinucumab 18
risankizumab 34
rituximab 20
rivabazumab 13
robatumumab 20
roledumab 23
romosozumab 19
rontalizumab 19
rosmantuzumab 19
rozanolixizumab 19
sacituzumab 21
sacituzumab_govitecan 21
samalizumab 22
sapelizumab 22
sarilumab 12
secukinumab 9
seribantumab 15
setoxaximab 41
sifalimumab 8
siltuximab 24
simtuzumab 26
sirukumab 10
solanezumab 22
solitomab 21
stamulumab 14
suptavumab 18
suvizumab 17
tabalumab 9
tadocizumab 12
tamtuvetmab 29
tanezumab 21
tarextumab 8
tavolixizumab 17
telisotuzumab 25
teplizumab 19
tesidolumab 17
tezepelumab 20
tigatuzumab 16
tildrakizumab 18
timolumab 15
tisotumab 12
tosatoxumab 29
tositumomab 26
tralokinumab 21
trastuzumab 20
tregalizumab 24
trevogrumab 12
ublituximab 28
urelumab 15
ustekinumab 23
utomilumab 25
vadastuximab 21
vadastuximab_talirin 21
vandortuzumab_vedotin 13
vantictumab 18
vanucizumab2 21
vanucizumab 23
varlilumab 12
vatelizumab 17
vedolizumab 24
veltuzumab 15
vesencumab 12
vorsetuzumab 17
vorsetuzumab_mafodotin 17
vunakizumab 32
xentuzumab 16
zatuximab 33
